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Background: Ebola viruses cause viral hemorrhagic fever in humans and non-human primates and are endemic in
Africa. Reston ebolavirus (REBOV) has caused several epizootics in cynomolgus monkeys (Macaca fascicularis) but is
not associated with any human disease. In late 2008, REBOV infections were identified in swine for the first time in
the Philippines.
Methods: A total of 215 swine sera collected at two REBOV-affected farms in 2008, in Pangasinan and Bulacan,
were tested for the presence of REBOV-specific antibodies using multiple serodiagnosis systems. A total of 98 swine
sera collected in a non-epizootic region, Tarlac, were also tested to clarify the prevalence of REBOV infection in the
general swine population in the Philippines.
Results: Some 70 % of swine sera at the affected farms were positive for REBOV antibodies in the multiple
serodiagnosis systems. On the other hand, none of the swine sera collected in Tarlac showed positive reactions in
any of the diagnosis systems.
Conclusions: The high prevalence of REBOV infection in swine in the affected farms in 2008 suggests that swine is
susceptible for REBOV infection. The multiple serological assays used in the study are thought to be useful for
future surveillance of REOBV infection in swine in the Philippines.
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The Ebola virus (EBOV) is an enveloped, negative-
strand RNA virus belonging to the family filoviridae in
the order of mononegavirale [1]. Four of the five ebola-
virus species, Zaire (ZEBOV), Sudan, Tai Forest, and
the recently discovered Bundibugyo ebolavirus, are
endemic in continental Africa and cause a severe form of
viral hemorrhagic fever with high mortality in humans
and non-human primates [2-6]. Reston ebolavirus
(REBOV) is sporadic in the Philippines and has caused
several epizootics in cynomolgus macaques [7]. REBOV
was first isolated in 1989 from cynomolgus macaques
imported from the Philippines for medical research in* Correspondence: morikawa@nih.go.jp
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reproduction in any medium, provided the orthe United States [7-10]. About 1,000 monkeys died or
were euthanized in a quarantine facility in Reston, Vir-
ginia. Subsequently, 21 animal handlers at the Philip-
pine exporter and four employees of the quarantine
facility were found to have antibodies to the virus, indi-
cating that they had been infected [11,12]. Epizootics in
monkeys in the Philippines were then reported in 1992
and 1996, and all the epizootics have been traced back
to a single monkey facility, in Calamba, Laguna in the
Philippines [11,13-16]. Since the closure of the facility
in 1997, no REBOV epizootics in cynomolgus monkeys
have been reported.
In October 2008, REBOV infection was confirmed for
the first time in swine associated with multiple epizoo-
tics of respiratory and abortion-related diseases in the
Philippines [17]. In several pools of swine samples col-
lected from geographically distant swine farms, co-l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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spiratory syndrome virus (PRRSV) was confirmed [17].
Serological studies of limited scale on 13 swine sera in
the affected farms failed to detect REBOV antibodies in
ELISA, although PRRSV antibodies were detected [17].
It is still unclear how REBOV was spread among swine
during the epizootic. Moreover, it is not clear if REBOV
infection in the swine population is either sporadic and
incidental or common in the Philippines. To try to an-
swer these questions, we prepared multiple serodiagnosis
systems for detecting REBOV infection in swine and
analyzed swine sera obtained from the affected farms
and from farms not associated with any epizootics in the
Philippines. The results showed a high prevalence of
REBOV infection in swine in the affected farms at the
epizootics in 2008; however, REBOV antibodies were not
detected in the swine population not associated with the
epizootics, indicating that REBOV infection in swine in
the Philippines is not common, at least in some parts
of Tarlac.Results
Detection of REBOV-NP and -GP antibodies in swine using
IFA
Swine sera were analyzed for the presence of REBOV-
NP and -GP antibodies in IFA specific to REBOV-NP
and -GP, respectively. In the IFA, none of the 49 swine
sera collected in Japan showed a positive reaction (data
not shown), and so they were considered to be
REBOV-NP and -GP antibody negative. In the IFA spe-
cific to REBOV-NP, antibody positive swine sera showed
characteristic granular staining patterns in the cytoplasm
(Figure 1A), which were indistinguishable from those of
REBOV-infected cynomolgus monkey sera [18] and
REBOV-NP immunized rabbit sera (data not shown).
Antibody-negative swine sera showed no reaction (Fig-
ure 1B). In the IFA specific to REBOV-GP, antibody
positive swine sera showed characteristic cellular surface
staining patterns (Figure 1C), which were indistinguish-
able from those of REBOV-infected cynomolgus monkey
sera and REBOV-GP immunized rabbit sera (data not
shown). Antibody-negative swine sera showed no reac-
tion (Figure 1D). In Bulacan, 104 (71.2%) and 115
(78.8%) of the 146 swine sera showed positive reactions
in the NP- and GP-specific IFA, respectively. In Pangasi-
nan, each 54 (78.3%) of the 69 swine sera showed posi-
tive reactions in the NP- and GP-specific IFA. In total,
158 (73.5%) and 169 (78.6%) of the 215 swine sera col-
lected at the affected farms were REBOV-NP and -GP
antibody positive in the IFA, respectively (Table 1). On
the other hand, none of the 98 swine sera collected in
Tarlac in the Philippines showed any positive reaction
(Table 1).Detection of REBOV neutralizing antibodies in swine
The VSV-pseudotype bearing REBOV-GP efficiently
infected Vero E6 cells which are known to be susceptible
to REBOV infection. The infectious titer of the VSV-
pseudotype reached 3.6 x 106 IU/mL when measured on
Vero E6 cells. Infection with the VSV-pseudotype was
neutralized with rabbit serum to REBOV-GP (data not
shown). Swine sera were analyzed in the NT using the
VSV-pseudotype. In the NT, none of the 49 swine sera
collected in Japan neutralized the infection with the
VSV-pseudotype on Vero E6 cells at serum dilutions of
1 in 100. These were therefore considered to be REBOV
NT antibody negative. In the affected farms, 108 (74.0%)
of the 146 swine sera in Bulacan and 46 (66.7%) of the
69 swine sera in Pangasinan showed positive reactions in
the NT, respectively at a serum dilution of 1 in 100. In
total, 154 (71.6%) of the 215 swine sera in the affected
farms showed NT antibody positive (Table 1). NT titers
of the sera were then obtained for the 34 NT antibody
positive sera in the affected farms. NT titers ranged be-
tween 100 and 12,800 with average of 790 and median
of 400 (data not shown). In Tarlac, none of the 98 swine
sera showed any positive reaction (Table 1).
Detection of REBOV-NP and -GP specific antibodies in
swine using IgG-ELISA
IgG antibodies to the REBOV-NP and -GP were
detected by recombinant REBOV protein-based IgG-
ELISA. The OD values to the NP and GP of each
serum sample at a dilution of 1 in 100 were plotted
(Figure 2A and B), and ROC and TG-ROC curves were
also drawn (Figure 2C to F). Since the OD values of
negative samples were very low, the cut off values
defined as the values at intersection points of the sensi-
tivity curve and specificity curve were 0.077 and 0.104
for REBOV-NP and -GP, respectively. At the cut off
values, sensitivity and specificity of the assay are over
95% in both IgG-ELISAs (Figure 2E and F). In Bulacan,
115 (78.8%) and 119 (81.5%) of the 146 swine sera
showed positive reactions in the NP- and GP-specific
IgG-ELISA, respectively. In Pangasinan, 62 (89.9%) and
46 (66.7%) of the 69 swine sera showed positive reac-
tions in the NP- and GP-specific IgG-ELISA, respect-
ively. In total, 177 (82.3%) and 165 (76.7%) of the 215
swine sera collected at the affected farms were
REBOV-NP and -GP antibody positive in the IgG-
ELISA, respectively (Table 1). Conversely, 1 of the 98
swine sera collected in Tarlac in the Philippines showed
a positive reaction in the GP specific IgG-ELISA and 1
of the 49 swine sera collected in Japan showed a posi-
tive reaction in the NP- and GP-specific IgG-ELISA
(Table 1). However, these results are considered to be
false positives because the OD values were close to the
cut off level defined by the assay, additionally all the
Figure 1 Detection of REBOV antibodies in IFA. Immunofluorescence staining pattern of HeLa cells expressing REBOV-NP (A) and REBOV-GP
(C) with a REBOV antibody positive swine serum at a dilution of 1 in 160. Negative staining pattern of HeLa cells expressing REBOV-NP (B) and
REBOV-GP (D) with a REBOV antibody negative swine serum (B and D).
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Table 1 Detection of REBOV-antibodies in swine
NP GP NT
IgG-ELISA IFA IgG-ELISA IFA
Bulacan 115/146 (78.8%) 104/146 (71.2%) 119/146 (81.5%) 115/146 (78.8%) 108/146 (74.0%)
Pangasinan 62/69 (89.9%) 54/69 (78.3%) 46/69 (66.7%) 54/69 (78.3%) 46/69 (66.7%)
Tarlac 0/98 (0%) 0/98 (0%) 1/98 (1.0%) 0/98 (0%) 0/98 (0%)
Japan 1/49 (2.0%) 0/49 (0%) 1/49 (2.0%) 0/49 (0%) 0/49 (0%)
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alternative serological assays were negative.
Agreement between the serological assays detecting
REBOV antibodies
We next examined the agreement between the sero-
logical assays used in the present study. The data
obtained in each assay were binarized to either positive
or negative result. These binarized data were then statis-
tically analyzed by pair-wise comparisons in nonpara-
metric one-way ANOVA. This analysis showed that
there were no significant differences between the sero-
logical assays (p> 0.05, data not shown). The result sup-
ports the contention that all of the five serological assays
used in the present study posses similar discriminatory
capacity. Thus we are confident that many REBOV anti-
body positive samples showed a positive reaction in all
of the five assays.Figure 2 Distribution of OD values and ROC and TG-ROC analyses of
(A) and GP (B) of each serum sample at a dilution of 1 in 100 were plotted
negative. ROC and two graph-ROC (TG-ROC) curves were analyzed and draDiscussion
ZEBOV and Marburg virus were identified in African
fruit bat species [19,20]. More recently, Marburg virus
was successfully isolated from a fruit bat, Rousettus
aegyptiacus [21], suggesting that fruit bats are reservoir
animals of filoviruses. In the Philippines, we have re-
cently demonstrated that an Asian fruit bat, Rousettus
amplexicaudatus, has antibodies to REBOV [22]. Since
the REBOV genome has not yet been detected in the
bat, conclusive evidence that the bat species is a reser-
voir, or one of the reservoir animals, of REBOV is not
available. Nevertheless, it is possible that REBOV was
transmitted to swine from these bats since these bats in-
habit many areas of the country, including the regions
around the affected facilities both in Pangasinan and
Bulacan.
In this study, we have aimed to clarify how REBOV in-
fection was spread among swine during the REBOVthe IgG-ELISA specific for REBOV-NP and -GP. OD values to the NP
for swine group showing either IF and NT antibody positive or
wn using Stat Flex software.
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the REBOV affected farms using IFA and IgG-ELISA
specific for REBOV-NP and -GP, and NT. NT is the gold
standard of serological assay in many virus infections.
However, since REBOV needs to be cultured in high-
containment laboratories, we performed an alternative
NT using the VSV-pseudotype bearing REBOV-GP. This
avoided the use of infectious REBOV, enabling the work
to be carried out at low containment. Previously it has
been shown that VSV-pseudotype bearing ebolavirus GP
mimicks ebolavirus infection [23], Approxymately 70%
of the swine sera from REBOV affected farms were
REBOV antibody positive. This indicated that swine are
susceptible to REBOV infection. Unfortunately, we could
not analyze the IgM antibody responses in swine, since
after the sera were heat inactivated the gamma globulin
fractions were precipitated with ammonium sulfate, and
reconstituted in PBS prior to be testing. An indication of
the IgM responses to REBOV would have provided evi-
dence of a recent infection. Thus, it is still unclear if
REBOV infection was spread during epizootics or
whether a population of the animals in the farms was
infected with REBOV prior to the epizootics. The swine
not associated with the epizootics, in Tarlac, are consid-
ered to be free from REBOV infection. These samples
were collected in 2010, over 2 years after the epizootic,
and from animals born after the epizootic. Moreover, we
could not analyze the swine specimens near the affected
farms in 2008. Thus, in this study, it is not clear if
REBOV infection in 2008 was limited in the affected
farms. Further study is necessary to conclude if the
swine population in the Philippines is generally free from
REBOV infection.
Recently, it has been shown that the experimental infec-
tion of swine with REBOV alone resulted in subclinical in-
fection with rapid clearance of the virus [24]. Alternatively,
ZEBOV has been shown to replicate to high titers in ex-
perimentally infected swine and to cause severe lung path-
ology resulting in transmission of the virus to naïve animals
[25]. Thus, swine has been shown experimentally to be
highly susceptible to ZEBOV infection. Furthermore, some
amino acid mutations in NP and/or VP24 in ZEBOV
resulted in adaptation of the virus to guinea pigs and mice
[26,27]. Thus, we cannot rule out the possibility that muta-
tions introduced in the REBOV genome during serial trans-
mission in swine will result in adaptation of the virus to
swine in future. In this regard, a regular serological survey
of REBOV infection in swine in the Philippines is desirable.
The serodiagnosis systems presented in this study might be
useful for such a survey.
Conclusions
The high prevalence of REBOV infection in swine at the
affected farms in 2008 suggests that swine are susceptiblefor REBOV infection. The multiple serological assays used
in the study are thought to be useful for future surveil-
lance of REOBV infection in swine in the Philippines.
Methods
Swine serum specimens
A total of 215 swine sera were collected from two
REBOV affected pig farms, located in Pangasinan and
Bulacan in 2008 (Figure 3). Of these, 146 sera were col-
lected from swine at the farm in Bulacan, and 69 were
collected from those in Pangasinan. Swine samples in
the affected farms were collected under quarantine of
the Philippines. The sera were kept frozen at the
Research Institute for Tropical Medicine (RITM) in the
Philippines until use. Ninety-eight swine sera were col-
lected from July to September 2010 from swine aged
between 2 and 20 months (median of 4.5 months) in
Tarlac in the Philippines, where no swine epizootic has
been documented. The swine specimens at Tarlac were
collected and used under approval of IRB (No. 2009-018)
of RITM, and informed consent was obtained from the
farm owners. Forty-nine swine sera collected at slaugh-
terhouse in 2006-7 in Japan, kindly supplied by Dr. T-C
Li at the National Institute of Infectious Diseases, were
used as REBOV antibody negative control sera. Swine
sera were inactivated at 56°C for 30 minutes, and then
the gamma globulin fractions were precipitated with
ammonium sulfate and reconstituted in phosphate buf-
fered saline (PBS).
Immunofluorescence assay (IFA) specific to REBOV-NP
and -GP using HeLa cells expressing the recombinant
protein
The entire cDNA of REBOV-GP ORF was amplified
from the swine lymph node specimen used for amplifica-
tion of the cDNA of NP by RT-PCR using the primers
REBOV-GP/F (5’-CGA AGC TTC GAA CAT GGG
GTC AGG ATA TCA ACT-3’) and REBOV-GP/R (5’-
CGA AGC TTC AAC ACA AAA TCT TAC ATA TAC
AAA G-3’) (the Hind III site is underlined). The
complete nucleotide sequence of the amplicon was
determined to be identical to that of Reston 08A (Gen-
Bank accession number FJ621583), indicating that the
specimen was collected from the same farm as that of
sample group A from which Reston 08A was isolated
[17]. The Hind III fragment of the amplicon was subse-
quently cloned into pKS336 [28], and the pKS336 plas-
mid with REBOV-GP, pKS336-pREBOV-GP, was used
for transfection. HeLa cells were transfected with
pKS336-pREBOV-GP using a FuGENE HD (Roche Diag-
nostics, Mannheim, Germany) according to the manu-
facturer’s instructions. The cells transfected with the
plasmids were selected with 3 μg/mL of blasticidin S-
hydrochloride (Invitrogen, CA, USA) in Dulbecco’s
Figure 3 A topographical map showing locations in the Philippines where swine serum samples were obtained. Swine serum samples
were collected at farms in three regions in the Philippines, Bulacan, Pangasinan and Tarlac. These regions were showed the numbers of
specimens and percentage of positivity using NT. The three locations and Laguna, where the Ferlite monkey facility used to be located, are
shown on a Google map (©2011 Google Map data ©2011 AND Europa Technologies).
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fetal calf serum (FCS). The selected cells were analyzed
for the expression of REBOV-GP in IFA using anti-
REBOV-GP rabbit serum. The cells expressing
REBOV-GP were spotted on multiwell slide glasses,
fixed in acetone, and used as antigens for IFA specific to
REBOV-GP. The IFA specific to REBOV-NP was per-
formed as described previously [18], with slight modifi-
cations. Mock-transfected HeLa cells were used asnegative control antigens in the IFA. The antigen slides
were incubated with serially diluted swine sera under
humidified conditions at 37°C for 1 hour. The antigen
slides were washed in PBS, then reacted with rabbit anti-
pig IgG conjugated with fluorescein isothiocianate
(FITC) (Bethyl, TX, USA) at a dilution of 1 in 100 at 37°
C for 1 hour. The slides were washed in PBS, covered
with cover glasses, and examined for staining patterns
under a fluorescence microscope fitted with appropriate
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antibody titer in the IFA was determined as the recipro-
cal of the highest dilution showing positive staining.
Generation of vesicular stomatitis virus (VSV)-pseudotype
bearing REBOV-GP
Generation of VSV-pseudotype bearing REBOV-GP was
performed as described previously [29-31]. Briefly, 293 T
cells were transfected with pKS336-pREBOV-GP and
cultured for 24 hours, and then the cells were infected
with VSVΔG* (kindly supplied by Prof. M.A. Whitt, Uni-
versity of Tennessee) [30,31] and cultured for 24 hours.
The culture supernatants were then collected, filtered
through a 0.22 μm-pore-size filter, and stored at -80°C
until use. The infectious titer (infectious unit, IU) of
VSV-pseudotype on Vero E6 cells was determined by
counting the number of Green Fluorescent Protein
(GFP)-expressing cells.
Neutralization test (NT)
The sera were diluted twofold from 1 in 100 with
DMEM containing 5% FCS and 1,000 IU of VSV-
pseudotype bearing REBOV-GP. The mixture was incu-
bated for 1 hour at 37°C, then inoculated onto Vero E6
cells seeded on 96-well plates. The numbers of VSV-
pseudotype infected cells were determined by counting
of the number of GFP-positive cells according to the
methods described previously [23,29,30]. NT titers of
the tested sera were defined as the reciprocals of the
highest dilutions at which more than 50% inhibition of
infectivity was observed. Serum samples were considered
to be NT antibody negative when less than 50% inhib-
ition of infectivity was observed at a dilution of 1 in 100.
Recombinant baculoviruses expressing recombinant
REBOV proteins
cDNA of REBOV nucleoprotein (NP) open reading frame
(ORF) from a swine lymph node specimen collected at the
farm in Bulacan was amplified by reverse transcription
polymerase chain reaction (RT-PCR), and the nucleotide
sequence of the amplicon was determined to be identical to
that of Reston 08A. The cDNA was subcloned into pGEM-
Teasy (Promega, WI, USA) and used for the following PCR
template. PCR was performed using the plasmid clone to
add BamHI linker with primers REBOV-NP/F (5’-GGG
CTA GCG GAT CCA AGT CGA TAT GGA TCG TGG
GAC C-3’) and REBOV-NP/R (5’-TTG CGG CCG CGG
ATC CCT GAT GGT GCT GCA AGA TTG-3’) (the re-
striction site is underlined). A BamHI-digested fragment of
the plasmid was then subcloned into pAcYM1-C-His plas-
mid, a derivative of pAcYM1 plasmid [32] carrying eight
histidine coding sequences just downstream of the BamHI
site, to construct pAcYM1-His-pREBOV-NP. A recombin-
ant baculovirus, Ac-His-pREBOV-NP, was generated usinga previously described method [33]. The recombinant
baculovirus, which expresses the ectodomain of REBOV-
glycoprotein (GP) with a histidine-tag at its carboxyl
terminus [22], was used to prepare recombinant REBOV-
GP for IgG-ELISA. A baculovirus (Ac-ΔP) that lacks the
polyhedorin gene was used to prepare a negative-control
antigen in insect cells.
Expression and purification of recombinant NP and GP of
REBOV in baculovirus
Tn5 insect cells were infected with Ac-His-pREBOV-NP
and Ac-His-REBOV-GP and then incubated at 26°C for
72 hours and 48 hours, respectively. The cells were
washed in PBS, lyzed in PBS containing 1% NP40 and
8 M urea, and then clarified by centrifugation at
8,000 rpm for 10 min. The supernatant fraction was col-
lected, and recombinant REBOV-NP and REBOV-GP
were purified using a Ni2 + -resin purification system
(QIAGEN, Düsseldorf, Germany) according to the man-
ufacturer’s instructions. The expression and purification
of REBOV-NP and REBOV-GP were confirmed in 10%
sodium dodecyl sulfate polyacrylamide gel electrophor-
esis (SDS-PAGE) and Coomassie Brilliant Blue R-250
staining Tn5 cells infected with Ac-ΔP were processed
similarly and used as negative control antigen in the
ELISAs. The purified antigens and negative control anti-
gen were kept at -80°C until use.
IgG-ELISA
Swine sera were analyzed for the presence of antibodies
to REBOV-NP and REBOV-GP in IgG-ELISA, essentially
as described previously [22,34,35]. Briefly, half of the
wells of the ELISA plates (Falcon, NJ, USA) were coated
with a predetermined optimal quantity (approximately
100 ng/well) of each purified recombinant protein, and
the rest of the wells were coated with the negative con-
trol antigens. After washing the plates three times in
PBS containing 0.05% Tween-20 (T-PBS; SIGMA-
ALDRICH, MO, USA), each well was incubated with
200 μL of T-PBS containing 5% skim milk (MT-PBS;
Yukijirushi, Hokkaido, Japan) for 1 hour at 37°C. After
washing the plates three times in T-PBS, the antigen-
coated and negative-control-antigen–coated wells were
inoculated with the test samples (100 μL/well) in MT-
PBS at a dilution of 1 in 100, incubated for 1 hour at 37°
C, and washed in T-PBS. Then, each well was incubated
with a Protein A/G conjugated with horseradish perox-
idase at a dilution of 1 in 1,500 (PIERCE, IL, USA) in
MT-PBS for 1 hour at 37°C. The plates were washed
three times, and 100 μL of ABTS solution (Roche Diag-
nostics, Mannheim, Germany) was added to each well.
The plates were incubated for 30 min, and the optical
density (OD) was measured at 405 nm with a reference
at 490 nm. The adjusted ODs for each tested sample
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control-antigen–coated wells from those of the corre-
sponding REBOV-antigen–coated wells.
Statistical methods
Sensitivity, specificity and predictive values for positive
and negative tests were calculated by standard methods.
Sensitivity and specificity were defined as the probability
that the target assay result was positive when the IFAs
specific to REBOV-NP and -GP and NT showed positive
and the probability that the target assay result was nega-
tive when the IFAs and NT showed negative, respect-
ively. Receiver operating characteristics (ROC) and two
graph-ROC (TG-ROC) curves were analyzed using Stat
Flex software (Artech Co. Ltd., Osaka, Japan) [36,37]. To
examine the agreement between the serological assays
used in the present study, we employed Friedman test
with Dunn's post-hoc test [38,39] using GraphPad Prism
using pair-wise comparisons in nonparametric one-way
ANOVA.
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